Voyager Therapeutics Inc (VYGR) Insider Trading
- $92,031,920.32
- $16,235,902.68
- April 2, 2025
- Bernard Ravina
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 2, 2025 | CEO | 10,885 | $3.43 | Sell | $37,335.55 | |
Jan. 14, 2025 | Insider | 1,191 | $5.13 | Sell | $6,109.83 | |
Jan. 14, 2025 | COO | 3,087 | $5.09 | Sell | $15,712.83 | |
Dec. 23, 2024 | COO | 6,500 | $5.65 | Sell | $36,725.00 | |
Oct. 2, 2024 | Insider | 5,999 | $5.82 | Sell | $34,914.18 | |
Jan. 17, 2024 | COO | 2,543 | $7.15 | Sell | $18,182.45 | |
Jan. 17, 2024 | Insider | 1,266 | $7.18 | Sell | $9,089.88 | |
Oct. 3, 2023 | CFO | 13,567 | $6.99 | Sell | $94,833.33 | |
Sept. 15, 2023 | Insider | 10,500 | $8.16 | Sell | $85,680.00 | |
July 6, 2023 | Insider | 5,500 | $10.80 | Sell | $59,400.00 | |
April 3, 2023 | COO | 1,259 | $7.83 | Sell | $9,857.97 | |
April 3, 2023 | CEO | 7,437 | $7.83 | Sell | $58,231.71 | |
March 20, 2023 | Insider | 2,193 | $7.76 | Sell | $17,017.68 | |
March 20, 2023 | COO | 3,654 | $7.76 | Sell | $28,355.04 | |
March 20, 2023 | VP | 4,410 | $7.76 | Sell | $34,221.60 | |
Feb. 23, 2023 | Major Shareholder | 4,395,588 | $8.88 | Buy | $39,032,821.44 | |
Feb. 17, 2023 | VP | 3,297 | $7.45 | Sell | $24,562.65 | |
Feb. 17, 2023 | Insider | 738 | $7.45 | Sell | $5,498.10 | |
Feb. 13, 2023 | Insider | 797 | $7.67 | Sell | $6,112.99 | |
Feb. 13, 2023 | VP | 2,868 | $7.67 | Sell | $21,997.56 | |
Feb. 1, 2023 | Major Shareholder | 128,642 | $9.32 | Sell | $1,198,943.44 | |
Jan. 30, 2023 | Major Shareholder | 75,000 | $9.03 | Sell | $677,250.00 | |
Jan. 27, 2023 | Major Shareholder | 50,000 | $9.02 | Sell | $451,000.00 | |
Jan. 25, 2023 | Major Shareholder | 50,000 | $9.22 | Sell | $461,000.00 | |
Jan. 23, 2023 | Major Shareholder | 55,000 | $9.06 | Sell | $498,300.00 | |
Jan. 20, 2023 | Major Shareholder | 100,000 | $9.15 | Sell | $915,000.00 | |
Jan. 17, 2023 | Insider | 1,106 | $9.85 | Sell | $10,894.10 | |
Jan. 17, 2023 | VP | 2,188 | $9.85 | Sell | $21,551.80 | |
Jan. 11, 2023 | Major Shareholder | 110,000 | $8.50 | Sell | $935,000.00 | |
Jan. 9, 2023 | Major Shareholder | 456,000 | $7.67 | Sell | $3,497,520.00 | |
Aug. 24, 2022 | Major Shareholder | 149,972 | $6.09 | Sell | $913,329.48 | |
Aug. 15, 2022 | Major Shareholder | 135,808 | $6.04 | Sell | $820,280.32 | |
Aug. 12, 2022 | Major Shareholder | 348,007 | $6.12 | Sell | $2,129,802.84 | |
July 14, 2022 | N/A | 13,891 | $6.70 | Sell | $93,069.70 | |
July 14, 2022 | N/A | 9,512 | $6.70 | Sell | $63,730.40 | |
July 14, 2022 | Director | 9,512 | $6.70 | Sell | $63,730.40 | |
June 23, 2022 | Major Shareholder | 376,000 | $5.66 | Buy | $2,128,160.00 | |
June 21, 2022 | Major Shareholder | 101,400 | $5.28 | Buy | $535,392.00 | |
April 4, 2022 | COO | 1,527 | $8.25 | Sell | $12,597.75 | |
April 4, 2022 | VP | 2,786 | $8.25 | Sell | $22,984.50 | |
March 21, 2022 | VP | 4,955 | $8.29 | Sell | $41,076.95 | |
March 21, 2022 | COO | 4,413 | $8.29 | Sell | $36,583.77 | |
Feb. 11, 2022 | VP | 3,252 | $3.36 | Sell | $10,926.72 | |
Jan. 12, 2022 | VP | 265 | $3.06 | Sell | $810.90 | |
Jan. 3, 2022 | VP | 3,063 | $2.83 | Sell | $8,668.29 | |
Jan. 12, 2021 | CFO | 2,942 | $8.62 | Sell | $25,360.04 | |
Jan. 12, 2021 | CEO | 10,443 | $8.62 | Sell | $90,018.66 | |
May 21, 2020 | Insider | 3,500 | $12.96 | Sell | $45,360.00 | |
April 3, 2020 | VP | 3,091 | $8.51 | Sell | $26,304.41 | |
Jan. 21, 2020 | CFO | 3,128 | $13.36 | Sell | $41,790.08 |
Insiders are both buying and selling Voyager Therapeutics Inc stock.
The insider traders at Voyager Therapeutics Inc are: Bernard Ravina, Rock Ventures Iii L.P. Third, Todd Alfred Carter, Robert W Hesslein, Robin Swartz, Ecor1 Capital, Llc, Jane Henderson, Alfred Sandrock, Allison Dorval, Andre Turenne, Glenn Pierce, James A Geraghty, Julie Burek, Neurocrine Biosciences Inc, Peter P Pfreundschuh, PIERCE GLENN, Omar Khwaja, Matthew P Ottmer, Higgins Michael J, Sandell Jacquelyn Fahey, Steven M Paul, and Dinah Ph.D. Sah
The most active insider trader at Voyager Therapeutics Inc is Bernard Ravina with 10 trades.
Rock Ventures Iii L.P. Third has sold the most Voyager Therapeutics Inc stock with a total value of $9,263,849.52.
Neurocrine Biosciences Inc has bought the most Voyager Therapeutics Inc stock with a total value of $128,055,189.76.
The most recent insider trade for Voyager Therapeutics Inc was on April 2, 2025.
The single biggest insider buy for Voyager Therapeutics Inc was from Neurocrine Biosciences Inc with a total value of $49,989,546.88 on March 12, 2019.
The single biggest insider sell for Voyager Therapeutics Inc was from Ecor1 Capital, Llc with a total value of $3,497,520.00 on Jan. 9, 2023.